Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab (ROTATE Trial)

NCT01845844 is registered in ClinicalTrials.gov with Southeast Retina Center, Georgia as lead sponsor.

NCT NCT01845844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01845844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab (ROTATE Trial)
Lead sponsor
Southeast Retina Center, Georgia
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2013
Completion date
January 31, 2015
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema